The use of haloperidol in agitated critically ill children.
Harrison
A Marc
AM
Department of Pediatric Critical Care Medicine, Cleveland Clinic Children's Hospital, Ohio, USA.
Lugo
Ralph A
RA
Lee
W Ellaria
WE
Appachi
Elumulai
E
Bourdakos
Demetrios
D
Davis
Stephen J
SJ
McHugh
Michael J
MJ
Weise
Kathryn L
KL
D000293:Adolescent; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002648:Child; D016638:Critical Illness; D005260:Female; D006220:Haloperidol; D006801:Humans; D007223:Infant; D007442:Intubation, Intratracheal; D008297:Male; D011595:Psychomotor Agitation / Q000188:drug therapy*; D012121:Respiration, Artificial
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D006220:Haloperidol